ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,230Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 434

$862K Total Retail Price of All Prescriptions

Rank: 6 out of 434

1,306 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,306 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 1,306 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 18,827 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,238 1,132 1 2
OMEPRAZOLE 1,217 1,073 2 5
LEVOTHYROXINE SODIUM 1,072 1,020 3 3
LISINOPRIL 972 909 4 1
AMLODIPINE BESYLATE 689 658 5 6
HYDROCODONE-ACETAMINOPHEN 643 505 S3 6 4
WARFARIN SODIUM 536 466 7 18
ATENOLOL 495 462 8 16
LOVASTATIN 423 409 9 10
PRAVASTATIN SODIUM 416 386 10 17
HYDROCHLOROTHIAZIDE 386 361 11 8
METFORMIN HCL 384 325 12 7
FUROSEMIDE 368 329 13 9
METOPROLOL TARTRATE 360 317 14 12
LOSARTAN POTASSIUM 356 336 15 13
GABAPENTIN 324 255 16 14
ALENDRONATE SODIUM 322 315 17 15
TRAZODONE HCL 320 263 18 33
CITALOPRAM HBR 304 218 19 23
TERAZOSIN HCL 261 256 20 40
POTASSIUM CHLORIDE 251 235 21 20
METOPROLOL SUCCINATE 247 239 22 22
FLUTICASONE PROPIONATE 216 201 23 26
ALLOPURINOL 216 197 23 25
ZOLPIDEM TARTRATE 214 155 25 11
TRAMADOL HCL 199 186 26 28
ATORVASTATIN CALCIUM 194 188 27 19
VENTOLIN HFA 185 169 28 30
GLYBURIDE 178 154 R 29 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 158 30 21
SERTRALINE HCL 170 146 31 27
CARVEDILOL 167 162 32 24
FLUOXETINE HCL 149 120 33 32
RANITIDINE HCL 145 123 34 31
PLAVIX 143 135 35 64
TAMSULOSIN HCL 140 133 36 29
AMITRIPTYLINE HCL 139 99 R 37 57
FINASTERIDE 131 107 38 54
DIGOXIN 122 102 39 69
GEMFIBROZIL 120 102 40 62
CLOPIDOGREL 119 103 41 41
POLYETHYLENE GLYCOL 3350 113 91 42 81
ISOSORBIDE MONONITRATE ER 112 104 43 68
PAROXETINE HCL 111 95 44 61
SYMBICORT 104 104 45 93
PREDNISONE 104 94 45 42
OXYBUTYNIN CHLORIDE ER 99 83 47 91
FOSINOPRIL SODIUM 98 92 48 228
QVAR 96 85 49 90
LOSARTAN-HYDROCHLOROTHIAZIDE 96 92 49 39
ACTOS 95 81 51 85
PEN NEEDLE 95 74 51 83
LANTUS SOLOSTAR 95 65 51 71
METFORMIN HCL ER 87 78 54 48
MELOXICAM 86 65 55 46
DONEPEZIL HCL 86 72 55 35
TRIAMTERENE-HCTZ 85 85 57 47
GLIPIZIDE 85 80 57 37
OXYCODONE HCL-ACETAMINOPHEN 84 68 S2 59 53
CLOTRIMAZOLE-BETAMETHASONE 83 75 60 124
CLONIDINE HCL 77 71 61 63
DILTIAZEM ER 73 73 62 98
SPIRIVA 71 71 63 36
CARBIDOPA-LEVODOPA 70 63 64 154
OXYCODONE-ACETAMINOPHEN 69 58 S2 65 74
CHOLESTYRAMINE 68 68 66 254
GLIPIZIDE ER 67 64 67 65
FENOFIBRATE 65 61 68 43
MIRTAZAPINE 65 53 68 97
VERAPAMIL ER 64 64 70 78
KLOR-CON 10 64 62 70 116
OXYBUTYNIN CHLORIDE 63 47 72 82
MECLIZINE HCL 63 63 72 159
ESTRADIOL 57 57 R 74 73
PROPRANOLOL HCL 54 54 75 102
GLYBURIDE-METFORMIN HCL 54 54 R 75 118
LANTUS 54 28 75 80
GLIMEPIRIDE 53 48 78 58
BISOPROLOL FUMARATE 52 52 79 283
NOVOLOG FLEXPEN 52 27 79 138
DICLOFENAC SODIUM 52 52 79 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.